EndoGastric Solutions

a leader in the endoluminal treatment of digestive diseases

  • Company
    • Management Team
    • Board of Directors
    • Investors
    • Corporate Compliance
    • Careers
  • EsophyX Technology
    • EsophyX® Device
    • SerosaFuse® Fasteners
    • Physician Training & Education for TIF Procedure with EsophyX Device
    • Regulatory Labeling
  • TIF Procedure
    • TIF vs Antireflux Surgery
    • TIF Procedure Reimbursement
    • Society Support
  • Data
    • Bibliography
    • Clinical Research
  • Support
    • Training and Education
    • TIF Procedure Reimbursement
    • Marketing Programs
  • News
    • Press Releases
    • Videos
    • Professional Events
    • Blog
  • Contact

Press Releases

EndoGastric Solutions Announces Publication of Meta-Analysis Further Validating TIF 2.0 procedure as an Appropriate Treatment Option for Refractory GERD Patients »

May 31, 2018

TIF Procedure offers excellent short and long-term relief for the majority of chronic GERD patients. REDMOND, Wash – EndoGastric® Solutions today announced the publication of a meta-analysis supporting the clinical utility of Transoral Incisionless Fundoplication (TIF®) 2.0 in the treatment of refractory gastroesophageal reflux disease (GERD). The TIF 2.0 procedure is a minimally invasive endoscopic option […] More »

EndoGastric Solutions Announces Publication of 5 Year TEMPO Data Confirming Lasting Improvement of GERD Symptoms with TIF 2.0 Procedure »

February 7, 2018

Cost comparison analysis indicates significantly lower healthcare utilization by TIF procedure patients REMOND, Wash. – EndoGastric® Solutions today announced that Surgical Innovation: Advances in Minimally Invasive Surgical Science, Technology, and Training has published five year follow-up data focused on control of GERD symptoms and healthcare economics after a Transoral Incisionless Fundoplication (TIF®) 2.0 procedure in […] More »

EndoGastric Solutions announces 100 Million Lives Now Covered for Transoral Incisionless Fundoplication Procedure »

January 4, 2018

Policy decisions by federal and commercial payers have expanded coverage for the TIF 2.0 procedure in 2018, extending access to effective long-term control of acid reflux symptoms REDMOND, Wash. – Federal and commercial payer plans responsible for over 100 million lives have recognized the value of EndoGastric Solutions’ TIF 2.0 procedure for gastroesophageal reflux disease (GERD) […] More »

EndoGastric® Solutions Debuts EsophyX® Z+ Device for Transoral Incisionless Fundoplication (TIF) Procedures »

November 29, 2017

New EsophyX Z+ device supports TIF 2.0 procedure with feature set of EsophyX Z device and benefits of adult sized endoscopes. REDMOND, Wash. – EsophyX® Z+ device offers expanded endoscope compatibility and joins EndoGastric Solutions’® portfolio of specialized technologies used to perform the TIF 2.0 procedure to reconstruct the gastroesophageal valve and restore its function […] More »

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 15
  • Next Page »

Find a Physician

Submit

Search Our Site

CONNECT

Receive the latest updates from GERDHelp.com


  • FACEBOOK

  • LINKEDIN

  • TWITTER

  • YOUTUBE

  • INSTAGRAM

Company

  • Company
  • Management Team
  • Board of Directors
  • Investors
  • Corporate Compliance
  • Careers

Technology

  • Technology (NOS)
  • EsophyX® Device
  • SerosaFuse® Fasteners
  • Physician Training & Education for TIF Procedure with EsophyX Device
  • Regulatory Labeling

TIF

  • TIF Procedure
  • TIF vs Antireflux Surgery
  • TIF Procedure Reimbursement
  • Society Support

Data

  • Data
  • Bibliography
  • European Bibliography
  • Clinical Research

News

  • News
  • Press Releases
  • Videos
  • Professional Events
  • Blog
AGA Tech Summit Sponsor

Contact

  • Contact

Support

  • Support
  • Training & Education
  • TIF Procedure Reimbursement
  • Marketing Programs

Physician Locator

  • Physician Finder

  • GERDHelp for Patients
  • References
  • Privacy
  • Terms of Use
  • Social Media Policy

This site is published by EndoGastric Solutions, Inc., and is intended as an information resource to help increase awareness of GERD-related disorders and the available treatment options. This site is not a substitute for medical advice from your physician. The contents of the site are for informational purposes only and are intended to be discussed with your physician. Never disregard any advice given to you by your physician or other qualified healthcare professional. Always seek the advice of a physician or other licensed healthcare professional regarding any questions you have about your medical conditions and treatments.
Terms of Use | Privacy Policy
© 2019 EndoGastric Solutions, Inc. All rights reserved. EndoGastric, EsophyX, SerosaFuse and TIF names and logos, are registered trademarks of EndoGastric Solutions.
All other product names and logos are trademarks or registered trademarks of their respective holders.

NP02410-01B

  • Company
    • Overview
    • Management Team
    • Board of Directors
    • Investors
    • Corporate Compliance
    • Careers
  • EsophyX Technology
    • Overview
    • SerosaFuse® Fasteners
    • EsophyX® Device
    • Physician Training & Education for TIF Procedure with EsophyX Device
    • Regulatory Labeling
  • TIF Procedure
    • Overview
    • Society Support
    • TIF vs Antireflux Surgery
    • TIF Procedure Reimbursement
  • Data
    • Overview
    • Bibliography
    • European Bibliography
    • Clinical Research
  • Support
    • Overview
    • Training and Education
    • TIF Procedure Reimbursement
    • Marketing Programs
  • News
    • Press Releases
    • Videos
    • Professional Events
    • Blog
  • Contact
  • Privacy
  • Social Media Policy
  • Terms of Use